HOLX Stock Recent News
HOLX LATEST HEADLINES
Hologic (HOLX) concluded the recent trading session at $64.14, signifying a -1.6% move from its prior day's close.
HOLX lifts margins despite tariffs and weak China sales, leaning on diagnostics strength and high-margin buys.
HOLX grapples with global headwinds, but growth in Diagnostics and Breast Health service lifts confidence.
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
After lagging for months, Hologic HOLX has picked up momentum in recent weeks. Shares of the Marlborough, MA-based company have climbed 13.3% over the past month, higher than the industry and the broader Medical sector's gains of 2.4% and 3.4%, respectively.
HOLX weathers Breast Health softness with rising service revenues, the Endomag acquisition and new tech on the horizon.
ARLINGTON, Va.--(BUSINESS WIRE)--NEST, an initiative of MDIC, is pleased to welcome Hologic, a leading global medical device company, to its Governance Committee.
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Private equity firms TPG and Blackstone BX recently bid to acquire Hologic Inc. HOLX, valuing the U.S. medical technology company at over $16 billion.
TPG and Blackstone Inc (NYSE:BX), two private equity firms, have made a non-binding offer of more than $16 billion to take medical equipment-maker Hologic Inc (NASDAQ:HOLX) private, according to a media report from the Financial Times. Citing people with knowledge of the matter, the publication said Massachusetts-based Hologic has rejected the offer.